Vision RT is a fast-growing MedTech company transforming radiation therapy for cancer patients by helping make it more accurate, effective, and comfortable. The company is the inventor of, and a market leader in, Surface Guided Radiation Therapy (SGRT). This technology uses advanced 3D cameras to track surface data, providing enhanced guidance across every step of the radiotherapy workflow.
Vision RT’s SGRT solutions are in 24 out of the 25 “Best Hospitals for Cancer,” as tracked by US News & World Report.
The company is recognized as one of Britain’s fastest-growing private tech companies, as featured in the 2025 Sunday Times 100 Tech list. Vision RT is also a recipient of the 2026 King’s Award for Enterprise, our fifth in 10 years. It is the UK’s most prestigious accolade for business excellence.
With around 300 employees globally and offices in the UK, Poland, and the USA, Vision RT operates independently as part of the Danish company William Demant Invest A/S, one of the world’s largest investors in healthcare companies. Employees benefit from the security and reach of being part of a large global enterprise, combined with the agility and innovation of a startup.
Vision RT is a company with strong values, a clear mission, and a bright future. It is an exciting and rewarding organization in which to work.
About the role
Well-established territory with a significant installed base of Align RT systems across Illinois, Indiana, Wisconsin, and Iowa. Success in the role will require a balance of driving upgrade sales within existing accounts while developing new business and replacement LINAC opportunities across the region.
Key Responsibilities
Essential Experience
Desirable Experience

Vision RT is the inventor of Surface Guided Radiation Therapy (SGRT) and produces a range of innovative solutions using computer vision and AI to ensure radiotherapy cancer treatment is delivered safely to the target.
As long as there is cancer, Vision RT will be tirelessly working to improve the accuracy, efficiency, safety and comfort of radiotherapy.